Cargando…
Umbilical Cord Blood-Derived Cell Therapy for Perinatal Brain Injury: A Systematic Review & Meta-Analysis of Preclinical Studies
Perinatal brain injury is a major contributor to long-term adverse neurodevelopment. There is mounting preclinical evidence for use of umbilical cord blood (UCB)-derived cell therapy as potential treatment. To systematically review and analyse effects of UCB-derived cell therapy on brain outcomes in...
Autores principales: | Nguyen, Timothy, Purcell, Elisha, Smith, Madeleine J., Penny, Tayla R., Paton, Madison C. B., Zhou, Lindsay, Jenkin, Graham, Miller, Suzanne L., McDonald, Courtney A., Malhotra, Atul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001969/ https://www.ncbi.nlm.nih.gov/pubmed/36901781 http://dx.doi.org/10.3390/ijms24054351 |
Ejemplares similares
-
Factors Influencing the Efficacy of Umbilical Cord Blood-Derived Cell Therapy for Perinatal Brain Injury
por: Purcell, Elisha, et al.
Publicado: (2023) -
Effects of umbilical cord blood cells, and subtypes, to reduce neuroinflammation following perinatal hypoxic-ischemic brain injury
por: McDonald, Courtney A., et al.
Publicado: (2018) -
Umbilical Cord Blood and Cord Tissue-Derived Cell Therapies for Neonatal Morbidities: Current Status and Future Challenges
por: Zhou, Lindsay, et al.
Publicado: (2022) -
Abstract 32 Expanded Umbilical Cord Blood CD34+ Cells Are Immunomodulatory in a Rat Model of Neonatal Brain Injury
por: Penny, Tayla, et al.
Publicado: (2023) -
Neural stem cell treatment for perinatal brain injury: A systematic review and meta‐analysis of preclinical studies
por: Smith, Madeleine J., et al.
Publicado: (2021)